• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6802892
Device Problems High Test Results (2457); Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/10/2023
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that lower and higher than expected vitros intact pth (ipth) quality control fluid results were obtained when processing non-vitros mas omni-immune qc fluids using two different vitros intact pth reagent lots in conjunction with two different vitros xt 7600 integrated systems.An assignable cause for the lower and higher than expected vitros ipth results could not be determined.A review of qc fluid results indicates there has been imprecision and accuracy issues at the customer site since the reagents were put into use.Therefore, a performance issue with vitros ipth reagent lots 1734 and 1760 cannot be ruled out as a contributor to the event.However, continual tracking and trending of complaints has not identified any signals that would indicate a systematic issue with vitros ipth reagent lots 1734 or 1760.Based on the acceptable quality control results obtained from within run precision testing using vitros tsh assay, an instrument issue is an unlikely contributor to the event.However, as no diagnostic within-run precision testing was performed on any of the two vitros xt 7600 integrated systems at the time of the events, an instrument related issue cannot be completely ruled out as contributing to the events.The customer did not state how long the qc fluids had been opened and stored between testing events.Additionally, there is inconsistency between the mas omni-immune instructions for use (ifu) and the vitros ipth ifu with regards to processing the qc fluids.Therefore, it is possible handling, storage and processing of the qc fluids could be a contributor to the events.
 
Event Description
The investigation determined that lower and higher than expected vitros intact pth (ipth) quality control fluid results were obtained when processing non-vitros mas omni-immune qc fluids using two different vitros intact pth reagent lots in conjunction with two different vitros xt 7600 integrated systems.Mas lot oim 2302 level 1 results of 10.04, 9.98, 12.31, 11.84, 9.99, 10.13, 10.28, 10.70, 14.24, 13.83, 13.39, 12.40, 10.75, 3.4, 7.47, 8.80, 11.46, 12.17, 12.69, 9.41, 10.93, 10.74, 10.33, 13.41, 12.49, 13.00, 10.68, 12.61, 11.81, 12.07 and 11.89 pg/ml versus the expected result of 21.00 pg/ml mas lot oim 2703 level 1 results of 38.4, pg/ml versus the expected result of 28.00 pg/ml mas lot oim 2411 level 2 results of 49.12, 50.93, 50.03, 31.51, 47.07, 40.56, 34.84, 33.65, 32.74, 25.92, 32.02 and 31.70 pg/ml versus the expected result of 76.90 pg/ml biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The lower and higher than expected vitros ipth results obtained were from non-patient fluids.Ortho is not aware of any reported allegation of patient harm as a result of this event.This report is number three of three mdr¿s for this event.Three 3500a forms are being submitted for this event as three devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint numbers (b)(4) and reportability assessment (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS, INC.
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
microtyping systems
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key18083603
MDR Text Key327515710
Report Number3007111389-2023-00191
Device Sequence Number1
Product Code CEW
UDI-Device Identifier10758750006267
UDI-Public10758750006267
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/27/2023
Device Catalogue Number6802892
Device Lot Number1760
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/21/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-